Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone.
de Castro LF, Michel Z, Pan K, Taylor J, Szymczuk V, Paravastu S, Saboury B, Papadakis GZ, Li X, Milligan K, Boyce B, Paul SM, Collins MT, Boyce AM.
N Engl J Med. 2023 Feb 23;388(8):766-768. doi: 10.1056/NEJMc2214862.
Barrett Esophagus.
Khieu M, Goosenberg E.
2025 May 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Fibroblast Activation Protein Is Expressed by Altered Osteoprogenitors and Associated to Disease Burden in Fibrous Dysplasia.
Raborn LN, Michel Z, Collins MT, Boyce AM, de Castro LF.
Cells. 2024 Aug 27;13(17):1434. doi: 10.3390/cells13171434.
Transcriptomic Signature and Pro-Osteoclastic Secreted Factors of Abnormal Bone-Marrow Stromal Cells in Fibrous Dysplasia.
Michel Z, Raborn LN, Spencer T, Pan KS, Martin D, Roszko KL, Wang Y, Robey PG, Collins MT, Boyce AM, de Castro LF.
Cells. 2024 Apr 30;13(9):774. doi: 10.3390/cells13090774.
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators.
Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18.
RANKL inhibition reduces lesional cellularity and Galpha(s) variant expression and enables osteogenic maturation in fibrous dysplasia.
de Castro LF, Whitlock JM, Michel Z, Pan K, Taylor J, Szymczuk V, Boyce B, Martin D, Kram V, Galisteo R, Melikov K, Chernomordik LV, Collins MT, Boyce AM.
Bone Res. 2024 Feb 20;12(1):10. doi: 10.1038/s41413-023-00311-7.
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cells.
Wentworth KL, Fierro FA, Moody TA, Le B, Michel Z, Boyce A, Collins M, Kram V, de Castro LF, Chow ED, Qorbani A, Hsiao EC.
Am J Hum Genet. 2025 Sep 4;112(9):2067-2087. doi: 10.1016/j.ajhg.2025.07.018. Epub 2025 Aug 22.
Treatment of esophagogastric junction carcinoma: an unsolved debate.
Orditura M, Galizia G, Lieto E, De Vita F, Ciardiello F.
World J Gastroenterol. 2015 Apr 21;21(15):4427-31. doi: 10.3748/wjg.v21.i15.4427.
The problems of moderate preterm infants.
Trembath AN, Payne AH, Colaizy TT, Bell EF, Walsh MC.
Semin Perinatol. 2016 Oct;40(6):370-373. doi: 10.1053/j.semperi.2016.05.008. Epub 2016 Sep 13.
Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers.
Mascaretti F, Haider S, Amoroso C, Caprioli F, Ramai D, Ghidini M.
J Gastrointest Cancer. 2024 Jun;55(2):662-678. doi: 10.1007/s12029-024-01021-x. Epub 2024 Feb 27.
